Dominique Arpin

Villefranche-sur-saone, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial.

Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial.

Journal: BMJ open

Published: July 29, 2026

Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis.

Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis.

Journal: Clinical lung cancer

Published: April 21, 2025

Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).

Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 20, 2024

Systemic nocardiosis with mediastinal lymph node involvement proven by endoscopic ultrasound

Systemic nocardiosis with mediastinal lymph node involvement proven by endoscopic ultrasound

Journal: Revue des maladies respiratoires

Published: June 09, 2021

PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study.

PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study.

Journal: Therapeutic advances in medical oncology

Published: February 16, 2020

Clinical Efficacy of Osimertinib in a Patient Presenting a Double EGFR L747S and G719C Mutation.

Clinical Efficacy of Osimertinib in a Patient Presenting a Double EGFR L747S and G719C Mutation.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: January 28, 2019

Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors.

Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 16, 2016

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study.

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study.

Journal: Targeted oncology

Published: August 29, 2015

Tumor-bronchial actinomycosis simulating a recurrence of lung cancer 14 years after initial treatment: A case report

Tumor-bronchial actinomycosis simulating a recurrence of lung cancer 14 years after initial treatment: A case report

Journal: Revue des maladies respiratoires

Published: November 15, 2013

Ineffectiveness of crizotinib on brain metastases in two cases of lung adenocarcinoma with EML4-ALK rearrangement.

Ineffectiveness of crizotinib on brain metastases in two cases of lung adenocarcinoma with EML4-ALK rearrangement.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 15, 2013

Routine EGFR molecular analysis in non-small-cell lung cancer patients is feasible: exons 18-21 sequencing results of 753 patients and subsequent clinical outcomes.

Routine EGFR molecular analysis in non-small-cell lung cancer patients is feasible: exons 18-21 sequencing results of 753 patients and subsequent clinical outcomes.

Journal: Lung

Published: February 19, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026